Netherlands Enterprise Agency (RVO) / rvo-01
Demonstrating disease pressure reduction through probiotic usage in Indonesia
NL-KVK-27378529-DHIF25D022
EUR 74kdeclared budget
EUR 66kdisbursed and spent, 7 of 9 transactions
Implementationstatus
30 Nov 2026actual end
Budget over time
- Reporting organisation
- Netherlands Enterprise Agency
- Start
- 01 May 2025
- Countries
- Indonesia 100.00%
- Sectors
- 12 · SDG goal 1.00%; Fishery development (31320) 100.00%; 8 · SDG goal 1.00%
- Funded by
- Netherlands Enterprise Agency
- Participating
- Tiptopp Aquaculture B.V. (implementing); Netherlands Enterprise Agency (accountable); Netherlands Enterprise Agency (funding); Noble Bioproducts B.V. (implementing)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:33 UTC
Changes
- 2026-10-03Transactions added
1 transaction added, EUR 9,871
Demonstrating disease pressure reduction through probiotic usage in Indonesia · compare 2b3a321c → efb2277c
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2025-06-30 → 2026-11-30 | original | EUR 74k | current |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2025-06-30 | Incoming funds | EUR 74k | |||
| 2025-06-30 | Outgoing commitment | EUR 74k | Noble Bioproducts B.V. | ||
| 2025-07-16 | Disbursement | EUR 9,871 | Noble Bioproducts B.V. | ||
| 2025-07-16 | Disbursement | EUR 6,987 | Noble Bioproducts B.V. | ||
| 2025-10-02 | Disbursement | EUR 9,871 | Noble Bioproducts B.V. | ||
| 2026-01-06 | Disbursement | EUR 9,871 | Noble Bioproducts B.V. | ||
| 2026-04-02 | Disbursement | EUR 9,871 | Noble Bioproducts B.V. | ||
| 2026-07-02 | Disbursement | EUR 9,871 | Noble Bioproducts B.V. | ||
| 2026-10-01 | Disbursement | EUR 9,871 | Noble Bioproducts B.V. | new |
Struck-through rows were in the previous version, last seen 2026-10-02 02:25 UTC, and are not in the current file.